Temporal Trends, Characteristics, and Outcomes of Infective Endocarditis After Transcatheter Aortic Valve Replacement.


Journal

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
ISSN: 1537-6591
Titre abrégé: Clin Infect Dis
Pays: United States
ID NLM: 9203213

Informations de publication

Date de publication:
06 12 2021
Historique:
received: 06 10 2020
accepted: 31 12 2020
pubmed: 19 3 2021
medline: 15 3 2022
entrez: 18 3 2021
Statut: ppublish

Résumé

Procedural improvements combined with the contemporary clinical profile of patients undergoing transcatheter aortic valve replacement (TAVR) may have influenced the incidence and outcomes of infective endocarditis (IE) following TAVR. We aimed to determine the temporal trends, characteristics, and outcomes of IE post-TAVR. Observational study including 552 patients presenting definite IE post-TAVR. Patients were divided in 2 groups according to the timing of TAVR (historical cohort [HC]: before 2014; contemporary cohort [CC]: after 2014). Overall incidence rates of IE were similar in both cohorts (CC vs HC: 5.45 vs 6.52 per 1000 person-years; P = .12), but the rate of early IE was lower in the CC (2.29‰ vs 4.89‰, P < .001). Enterococci were the most frequent microorganism. Most patients presented complicated IE ( CC: 67.7%; HC: 69.6%; P = .66), but the rate of surgical treatment remained low (CC: 20.7%; HC: 17.3%; P = .32). The CC exhibited lower rates of in-hospital acute kidney injury (35.1% vs 44.6%; P = .036) and in-hospital (26.6% vs 36.4%; P = .016) and 1-year (37.8% vs 53.5%; P < .001) mortality. Higher logistic EuroScore, Staphylococcus aureus etiology, and complications (stroke, heart failure, and acute renal failure) were associated with in-hospital mortality in multivariable analyses (P < .05 for all). Although overall IE incidence has remained stable, the incidence of early IE has declined in recent years. The microorganism, high rate of complications, and very low rate of surgical treatment remained similar. In-hospital and 1-year mortality rates were high but progressively decreased over time.

Sections du résumé

BACKGROUND
Procedural improvements combined with the contemporary clinical profile of patients undergoing transcatheter aortic valve replacement (TAVR) may have influenced the incidence and outcomes of infective endocarditis (IE) following TAVR. We aimed to determine the temporal trends, characteristics, and outcomes of IE post-TAVR.
METHODS
Observational study including 552 patients presenting definite IE post-TAVR. Patients were divided in 2 groups according to the timing of TAVR (historical cohort [HC]: before 2014; contemporary cohort [CC]: after 2014).
RESULTS
Overall incidence rates of IE were similar in both cohorts (CC vs HC: 5.45 vs 6.52 per 1000 person-years; P = .12), but the rate of early IE was lower in the CC (2.29‰ vs 4.89‰, P < .001). Enterococci were the most frequent microorganism. Most patients presented complicated IE ( CC: 67.7%; HC: 69.6%; P = .66), but the rate of surgical treatment remained low (CC: 20.7%; HC: 17.3%; P = .32). The CC exhibited lower rates of in-hospital acute kidney injury (35.1% vs 44.6%; P = .036) and in-hospital (26.6% vs 36.4%; P = .016) and 1-year (37.8% vs 53.5%; P < .001) mortality. Higher logistic EuroScore, Staphylococcus aureus etiology, and complications (stroke, heart failure, and acute renal failure) were associated with in-hospital mortality in multivariable analyses (P < .05 for all).
CONCLUSIONS
Although overall IE incidence has remained stable, the incidence of early IE has declined in recent years. The microorganism, high rate of complications, and very low rate of surgical treatment remained similar. In-hospital and 1-year mortality rates were high but progressively decreased over time.

Identifiants

pubmed: 33733675
pii: 6176669
doi: 10.1093/cid/ciaa1941
doi:

Types de publication

Journal Article Observational Study Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e3750-e3758

Subventions

Organisme : Fundación Alfonso Martin Escudero

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Auteurs

David Del Val (D)

Quebec Heart and Lung Institute, Laval University, Quebec City, Canada.

Mohamed Abdel-Wahab (M)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Heart Center, Segeberger Kliniken, Bad Segeberg, Germany.

Axel Linke (A)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Herzzentrum Dresden, Technische Universität Dresden, Dresden, Germany.

Eric Durand (E)

Hôpital Charles Nicolle, University of Rouen, Rouen, France.

Nikolaj Ihlemann (N)

Righospitalet, Copenhagen, Denmark.

Marina Urena (M)

Bichat Hôpital, Paris, France.

Costanza Pellegrini (C)

Deutsches Herzzentrum München, Munich, Germany.

Francesco Giannini (F)

Ospedale San Raffaele, Milan, Italy.
Maria Cecilia Hospital, GVM Care and Research, Cotignola RA, Italy.

Martin Landt (M)

Heart Center, Segeberger Kliniken, Bad Segeberg, Germany.

Vincent Auffret (V)

Centre Hospitalier Universitaire de Rennes, Rennes, France.

Jan Malte Sinning (JM)

Heart Center Bonn, Bonn, Germany.

Asim Cheema (A)

St Michaels Hospital, Toronto, Canada.
Southlake Regional Health Centre, Newmarket, Canada.

Luis Nombela-Franco (L)

Cardiovascular Institute, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.

Chekrallah Chamandi (C)

Hôpital Européen Georges Pompidou, Paris, France.

Francisco Campelo-Parada (F)

Hôpital Rangueil, Toulouse, France.

Antonio Munoz-Garcia (A)

Hospital Universitario Virgen de la Victoria, Malaga, Spain.

Howard C Herrmann (HC)

Hospital of the University of Pennsilvania, Philadelphia, Pennsylvania, USA.

Luca Testa (L)

IRCCS Pol San Donato, Milan, Italy.

Kim Won-Keun (K)

Kerckhoff Klinik, Bad Nauheim, Germany.

Juan Carlos Castillo (JC)

Hospital Universitario Reina Sofia, Cordoba, Spain.

Alberto Alperi (A)

Hospital Universitario Central de Asturias, Oviedo, Spain.

Didier Tchetche (D)

Clinique Pasteur, Toulouse, France.

Antonio Bartorelli (A)

Centro Cardiologico Monzino, IRCCS, University of Milan, Italy.

Samir Kapadia (S)

Cleveland Clinic, Cleveland, Ohio, USA.

Stefan Stortecky (S)

Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Switzerland.

Ignacio Amat-Santos (I)

CIBERCV, Hospital Clinico Universitario de Valladolid, Valladolid, Spain.

Harindra C Wijeysundera (HC)

Sunnybrook Health Science Center, Toronto, Canada.

John Lisko (J)

Emory University School of Medicine, Atlanta, Georgia, USA.

Enrique Gutiérrez-Ibanes (E)

Instituto de Investigación Universitaria Gregorio Marañón, Hospital Gregorio Marañón, Madrid, Spain.

Vicenç Serra (V)

Hospital Vall d'Hebron, Barcelona, Spain.

Luisa Salido (L)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

Abdullah Alkhodair (A)

St Paul's Hospital, Vancouver, Canada.

Ugolino Livi (U)

University Hospital of Udine, Udine, Italy.

Tarun Chakravarty (T)

Cedars-Sinai Heart Institute, Los Angeles, California, USA.

Stamatios Lerakis (S)

Emory University School of Medicine, Atlanta, Georgia, USA.
Mount Sinai Hospital, New York, New York, USA.

Victoria Vilalta (V)

Hospital Germans Trias i Pujol, Badalona, Spain.

Ander Regueiro (A)

Hospital Clinic, Barcelona, Spain.

Rafael Romaguera (R)

Hospital de Bellvitge, L'Hospitalet de Llobregat, Spain.

Marco Barbanti (M)

A.O.U. Policlinico Vittorio Emanuele, University of Catania, Catania, Italy.

Jean-Bernard Masson (JB)

Centre Hospitalier de l'Universite de Montreal, Montreal, Canada.

Frédéric Maes (F)

Cliniques Universitaires Saint-Luc, Brussels, Belgium.

Claudia Fiorina (C)

ASST-Spedali Civili di Brescia, Brescia, Italy.

Antonio Miceli (A)

Fondazione Toscana G. Monasterio, Massa, Italy.
Istituto Clinico Sant'Ambrogio, Milan, Italy.

Susheel Kodali (S)

Columbia University Medical Center, New York, New York, USA.

Henrique B Ribeiro (HB)

Instituto do Coração (Incor), Heart Institute, University of São Paulo, Sao Paulo, Brazil.

Jose Armando Mangione (JA)

Hospital Beneficencia Portuguesa, Sao Paulo, Brazil.

Fabio Sandoli de Brito (FS)

Instituto do Coração (Incor), Heart Institute, University of São Paulo, Sao Paulo, Brazil.

Guglielmo Mario Actis Dato (GM)

Ospedale Mauriziano, Torino, Italy.

Francesco Rosato (F)

Azienda Ospedaliera Santa Croce e Carle, Cuneo, Italy.

Maria-Cristina Ferreira (MC)

Hospital Naval Marcilio Dias, Rio de Janeiro, Brazil.

Valter Correa Lima (VC)

Hospital Sao Francisco-Santa Clara, Porto Alegre, Brazil.

Alexandre Siciliano Colafranceschi (AS)

Hospital Pró-cardíaco, Rio de Janeiro, Brazil.

Alexandre Abizaid (A)

Instituto Dante Pazzanese de Cardiologia, São Paulo, Brazil.

Marcos Antonio Marino (MA)

Hospital Madre Teresa, Belo Horizonte, Brazil.

Vinicius Esteves (V)

Hospital Sao Luiz, São Paulo, Brazil.

Julio Andrea (J)

Clínica Sao Vicente, Rio de Janeiro, Brazil.

Roger R Godinho (RR)

Hospital Samaritano Paulista, São Paulo, Brazil.

Helene Eltchaninoff (H)

Hôpital Charles Nicolle, University of Rouen, Rouen, France.

Lars Søndergaard (L)

Righospitalet, Copenhagen, Denmark.

Dominique Himbert (D)

Bichat Hôpital, Paris, France.

Oliver Husser (O)

Deutsches Herzzentrum München, Munich, Germany.
St-Johannes-Hospital, Dortmund, Germany.

Azeem Latib (A)

Ospedale San Raffaele, Milan, Italy.
Montefiore Medical Center, New York, New York, USA.

Hervé Le Breton (H)

Centre Hospitalier Universitaire de Rennes, Rennes, France.

Clement Servoz (C)

Hôpital Rangueil, Toulouse, France.

Isaac Pascual (I)

Hospital Universitario Central de Asturias, Oviedo, Spain.

Saif Siddiqui (S)

Clinique Pasteur, Toulouse, France.

Paolo Olivares (P)

Centro Cardiologico Monzino, IRCCS, University of Milan, Italy.

Rosana Hernandez-Antolin (R)

Hospital Universitario Ramón y Cajal, Madrid, Spain.

John G Webb (JG)

St Paul's Hospital, Vancouver, Canada.

Sandro Sponga (S)

University Hospital of Udine, Udine, Italy.

Raj Makkar (R)

Cedars-Sinai Heart Institute, Los Angeles, California, USA.

Annapoorna S Kini (AS)

Mount Sinai Hospital, New York, New York, USA.

Marouane Boukhris (M)

Centre Hospitalier de l'Universite de Montreal, Montreal, Canada.

Norman Mangner (N)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Herzzentrum Dresden, Technische Universität Dresden, Dresden, Germany.

Lisa Crusius (L)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.
Herzzentrum Dresden, Technische Universität Dresden, Dresden, Germany.

David Holzhey (D)

Heart Center Leipzig at University of Leipzig, Leipzig, Germany.

Josep Rodés-Cabau (J)

Quebec Heart and Lung Institute, Laval University, Quebec City, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH